Edwards' Intuity heart valve promising – early data
This article was originally published in Clinica
Executive Summary
Intuity, a new surgical heart valve developed by Edwards Lifesciences, has met with success in an early clinical trial.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.